Kwality Pharmaceuticals Ltd - Board Meeting Intimation for Considering The Standalone & Consolidated Audited Financial Results For The 4Th Quarter And Financial Year Ended On 31St March, 2024

Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2024 ,inter alia, to consider and approve the Standalone & Consolidated audited financial results for the fourth quarter and financial year ended on 31st March, 2024.Further, as per our earlier communication vide our letter dated 30th March, 2024 and in accordance with the Company's Code of Conduct for Prohibition of Insider Trading framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading window for dealing in Securities of the Company for all the Board of Directors, Designated Persons and their immediate relatives will remain closed till 48 hours after the financial results of the Company are made public on May 23, 2024.This is for your information and record.